Reducing Urban Cervical Cancer Disparities

Recruiting now · Not applicable

Conditions studied: Cervical Cancer, Papilloma Viral Infection

In brief

This study uses a hybrid Type 1 effectiveness-implementation trial to operationalize and assess the efficacy of the Health Enhancement Resource System (HERS) intervention. HERS aims to increase patient follow-up after abnormal test results through text message-based barriers counseling for women and supplemental telephone-based Health Coaching for women who miss their appointment.

Key facts

Study ID

NCT06416150

Run by

Fox Chase Cancer Center

People needed

546

Starts

2024-08-28

Expected to finish

2027-12-01

Last updated by the study team

2024-10-26

Who can join

Age: 18 and older, up to 90. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• 18 to 90 years of age (screening is still recommended for some women over 65-depending on screening and medical history and proceeds until age 90 in the study's clinic recruitment sites),
• referral for colposcopic evaluation at the clinic sites,
• able to communicate with ease in English,
• have a cell phone with texting ability, and
• competent to give consent.

You may not qualify if…

• are pregnant at the time of recruitment,
• display current evidence or have a history of positive invasive carcinoma of the cervix, or
• require follow-up but not a colposcopy.

Where it is running

• Rutgers, The State University of New Jersey — New Brunswick, New Jersey, United States (enrolling)
• Thomas Jefferson University — Philadelphia, Pennsylvania, United States (enrolling)
• Fox Chase Cancer Center — Philadelphia, Pennsylvania, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.